Monat: November 2016

Irvine, CA and Karlsruhe, Germany – November 28^th, 2016 – joimax^®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally invasive spinal surgery, again exhibited at Chinese Orthopedic Association (COA), which has taken place from Nov 17^th to 20^th, 2016 at China National Convention Center in Beijing, China. During the exhibition, the new NASS – joimax^® MISS Training Centre has been inaugurated.

The 18^th Chinese Orthopedic Association Annual Meeting and the 11^th International Congress of Chinese Orthopedic Association (COA) this year has again taken place in Beijing and was visited by around 35,000 surgeons gathering for the latest research results and up to date information on technology and clinical progression in orthopedics including Spine Surgery. joimax^® had a major presence with a large booth showing its endoscopic minimally invasive product range. Furthermore on the two major meeting days 30 lectures of well-known experts were given at its booth.

During the COA the new NASS-joimax^® MISS Training Centre in China has been inaugurated on Friday Nov. 18^th, 2016. The ceremony has taken place at the joimax^® booth together with leaders from the Peking University Third Hospital and members of the NASS Board of Directors. The Chinese market is a very important one for joimax^®: Chinese surgeons are highly interested in adopting and deepening their knowledge in endoscopic minimally invasive techniques. joimax^® is playing a major role in advanced training and is a driving power in the field of continuing education.

“With the launch of TESSYS^® IseeU^TM, which has been newly designed especially for the Chinese market, joimax^® offers an even more simplified access under facilitated orientation”, says Wolfgang Ries, CEO and founder of joimax^®. “The existing TESSYS^® trays can furthermore be upgraded with the TESSYS^® ISeeU^TM supplements” he continues.

Moreover, joimax^® also presented its latest product, the newly launched Intracs^® Interaoperative Navigation Tracking & Control System for the first time in China.

Irvine, CA and Karlsruhe, Germany – November 9^th, 2016 – joimax^®, the global acting German developer and marketer of technologies and training methods for endoscopic minimally-invasive spinal surgery, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Vaporflex^® and Legato^® electrosurgical probes with radiowave technology for open and endoscopic spine surgery.

Those joimax^® Electrosurgical Instruments are comprised of a series of instruments to facilitate the delivery of electrical energy from an RF generator to the patient tissue for use in cutting and/or coagulation of tissue. All Vaporflex^® and Legato^® probes use radio frequency which is generated by high oscillating electrical current received from a commercially available RF generator.

The new Vaporflex^® system is optimized for versatile use due to different lengths, diameters and probe tips to allow endoscopic transforaminal and interlaminar procedures. It is both compatible and cleared also for the use with all Endovapor^®/SurgiMax^® and SurgiMax^® Plus electrosurgical units and enables an easy swap of the Triggerflex^® to the new Vaporflex^® system. The bipolar Vaporflex^® probes can easily be adopted to the complete range of joimax^® systems. joimax^® offers all its probes in a kit containing a sterilization tray, the hand piece as well as a shaft and a connection cable.

The monopolar and bipolar Legato^® probes which support the rhizotomy procedures with the existing Multiuse and both newly launched products MultiZYTE^® RT for Facet Joint Denervation and MultiZYTE^® SI for SI Joint Therapy.

“Both the Vaporflex^® and Legato^® probes are ready for several generations of radiofrequency generators” says Wolfgang Ries, CEO and founder of joimax^®. “Spinal surgeons are now enabled to perform the range of joimax^® procedures with even more flexibility and ergonomics in the USA as well. This way we further enhance surgical interventions in endoscopic minimally-invasive spinal surgery” he continues.